Rapid HTAs of seventeen medical devices released in Tuscany


Dec 2021

The HTA body of the Tuscany Regional Healthcare issues two types of documents: HTA forms and motivational forms. With a regional decree 20520 of November 22, 2021, Tuscany Regional Healthcare has published assessments of seventeen medical devices of various therapeutic areas, including devices belonging to neurology, as well as gastrointestinal, urology, cardiovascular, orthopedics, peripheral vascular, and other fields of care.

Below is the list of technologies that have been assessed:

  • Pascal Mitral Ace mitral valve transcatheter repair system;
  • Pascal Tricuspid Ace tricuspid valve transcatheter repair system;
  • Bundle introduction system for implantation of leads in specific sites (His pacing) and lead;
  • M. blue Plus ventricular shunt system for the treatment of hydrocephalus;
  • Reemex sling system (adjustable over time) for urinary incontinence;
  • Serasynth synthetic mesh for breast surgery reconstruction;
  • Hybrid Aortic System (AMDS);
  • Histolock Resection Device (polypectomy snare);
  • Micra AV transcatheter pacing system;
  • Megasystem M-C Upper Limb P modular shoulder prosthesis;
  • Hy Tissue surgical field kit for centrifugation of fat from adipose tissue;
  • RELIEF long-term pleural and peritoneal drainage system;
  • Tessys transforaminal endoscopic surgical system;
  • HANAROSTENT fully covered stent for bile duct stenosis;
  • WavelinQ TM EndoAVF system for the endovascular creation of an arteriovenous fistula;
  • Sinovial H-L for intra-articular use in patients with hemophilia;
  • Figulla Flex II PFO Occutech occluder device for the closure of atrial defects.

See the regional decree and all assessments in Italian here or here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks). First EU issues of both newsletters are available for download free-of-charge.

The latest related news


May 2022

The French National Authority for Health (HAS) released new recommendations about add-on reimbursement of medical devices and medical aids from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS) in April 2022. Thirty recommendations were published in relation to the registration, modification of registration conditions, and renewal of registration for devices in the List of reimbursable products and services (LPPR). Opinions concern cardiovascular and peripheral vascular, orthopedic, neurovascular, and neuromodulation and other devices, as well as medical aids.

Read more


May 2022

In April 2022, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclatures for private payers in England, published Bulletins 0183 and 0080 with changes to be implemented no later than June 14, 2022. Eleven new procedure codes and nine new diagnostic codes were introduced.

Read more


May 2022

In Q1 of 2022, Health Technology Wales (HTW) published one MedTech-related guidance on transcranial magnetic stimulation in depression treatment. A total of eleven Topic Exploration Reports (TERs) were released in Q1. Based on the TERs conclusions, HTW's Assessment Group decided to proceed with developing an Evidence Appraisal Report (EAR) and Guidance on one topic only - radiofrequency renal denervation for the treatment of resistant hypertension.

Read more


May 2022

On April 4, 2022, the Innovation Committee at the Federal Joint Committee (G-BA) announced funding from the G-BA Innovation Fund for 18 innovative healthcare research projects dedicated to medical guidelines.

Read more


Apr 2022

In March 2022, the National Institute for Health and Care Excellence (NICE) published five new Interventional Procedure Guidance (endoscopic balloon dilation for subglottic or tracheal stenosis, intramedullary distraction for lower limb lengthening, endoscopic full thickness removal of gastrointestinal stromal tumors of the stomach, percutaneous insertion of a cystic duct stent after cholecystostomy, and liposuction for chronic lipoedema), four new Medical Technologies Guidance (myCOPD, UroShield, Prontosan for wounds, and 3C Patch for diabetic foot ulcers), one new Diagnostic Guidance (terminated assessment of Freelite assays for multiple myeloma), and six new Medtech Innovation Briefings (Genedrive MT-RNR1 ID System, icobrain for multiple sclerosis, Al for analyzing chest X-ray images, and others). Also, three new clinical guidelines were published, and six were updated.

Read more